Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02684526 · ClinicalTrials.gov registry record · NA
Is Eovist Suitable for Arterial-Phase MR Imaging of Liver
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 198
- Enrollment target
NCT02684526: Completed NA study, sponsored by University of Michigan.
NCT02684526 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 198 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02684526, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 198 participants
- Enrollment target
Study Summary
To examine the quality of liver images produced when the contrast agent Eovist is used during MRI.
Primary Outcome
To qualitatively assess and score MRI images during unenhanced and contrast-enhanced motion-sensitive sequences for breathing artifacts when Eovist contrast is used versus other contrast agents. Eovist enhanced MRI scans will be compared to previous MRI scans performed with other contrast agents on the same patient that included breath holding sequences. Breathing artifacts on both scans will be evaluated using a respiratory motion score between 1 and 5.
Interventions
- PROCEDURE Eovist Contrast
- PROCEDURE Non Eovist Contrast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2011-12 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT02684526 record still lists
NCT02684526 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Eovist Contrast is the first listed.
NCT02684526 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02684526 about?
NCT02684526 is a clinical study titled "Is Eovist Suitable for Arterial-Phase MR Imaging of Liver". To examine the quality of liver images produced when the contrast agent Eovist is used during MRI.
What is the current status of trial NCT02684526?
This trial is currently completed. It is a NA study. The enrollment target is 198 participants. The study started on 2011-12. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02684526?
The interventions under investigation include: Eovist Contrast (PROCEDURE), Non Eovist Contrast (PROCEDURE).
Who is sponsoring clinical trial NCT02684526?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02684526's enrollment target sits among peer trials
198 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia